A glowing light bulb full of ideas
The Signal

Expert insights and opinions on clinical research and drug development.

Expert insights and opinions on clinical research and drug development.

Category: Scientific Advisory

Myasthenia Gravis: Reducing Outcome Measures Variability in Clinical Trials

June is ‘Myasthenia Gravis Awareness’ month and a great opportunity to raise awareness of this rare autoimmune disease that, like…

11 Perspectives on the Present and Future of Clinical Development

The clinical trial landscape continues to undergo rapid transformation, spurred by shifting industry paradigms and evolving regulatory guidance, among other…

ISCTM 2022: Scientific Posters Compilation

Signant’s neuroscience team and CNS experts presented scientific posters at the 2022 Autumn Conference hosted by the International Society for…

AAIC 2022: Scientific Posters Compilation

Signant’s neuroscience team and CNS experts presented scientific posters at the 2022 Alzheimer’s Association International Conference in San Diego, California,…

Get to Know the SME – Lew Fredane

Were you always interested in neurology? If not, what did you originally want to be and why?  Not at all –…

With Sensors and Wearables, It’s Not All About the Hardware

The rapid adoption and incorporation of technology into many aspects of clinical research enables new opportunities to improve drug development….

ASCP 2022: Scientific Posters Compilation

Signant’s psychiatry experts and CNS thought leaders presented scientific posters at the American Society of Clinical Psychopharmacology’s 2022 annual meeting…

Get to Know the SME: Manuela Bossi

My scientific background is in psychology, and I have years of clinical research experience. I have always been driven by the…

Signant Health’s Clinical Scientist Jennifer Olt Receives ISCTM New Investigator Award

Jennifer Olt, Ph.D., a Clinical Scientist from Signant Health’s Operations – Clinical Science team, accepted a 2022 New Investigator Award…

5 Tips for Success in Rare Disease Studies

Before you begin planning your rare disease study, it’s important to identify potential challenges. At Signant, we believe that the…